CN105664224B - A kind of compound alginic acid dressing of low molecular weight carboxymethyl chitosan and preparation method thereof - Google Patents
A kind of compound alginic acid dressing of low molecular weight carboxymethyl chitosan and preparation method thereof Download PDFInfo
- Publication number
- CN105664224B CN105664224B CN201610103647.6A CN201610103647A CN105664224B CN 105664224 B CN105664224 B CN 105664224B CN 201610103647 A CN201610103647 A CN 201610103647A CN 105664224 B CN105664224 B CN 105664224B
- Authority
- CN
- China
- Prior art keywords
- molecular weight
- carboxymethyl chitosan
- low molecular
- alginic acid
- dressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
Landscapes
- Health & Medical Sciences (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
Abstract
The invention discloses a kind of compound alginic acid dressing of low molecular weight carboxymethyl chitosan, including component and mass ratio are as follows: low molecular weight carboxymethyl chitosan 0.1~8.0%, surplus are alginic acid non-woven fabrics;It the effect of by filtering out existing inhibition bacterium medical grade low-molecular weight chitoglycan carboxy methylation while after not generating cytotoxic concentration, is fixed in alginic acid non-woven fabrics and is formed.In use process, after dressing is by the interstitial fluid contacts with the surface of a wound, it discharges rapidly out carboxymethyl chitosan and plays bacteriostasis efficacy, the fully connected topology of alginic acid prevents carboxymethyl chitosan from discharging completely simultaneously, so that composite material has certain lasting fungistatic effect, dressing of the present invention has good gas permeability, mechanical stretch, hygroscopicity, antibiotic property and biocompatibility.Preparation process is relatively easy, and large-scale production feasibility is strong.Dressing of the present invention is suitable for skin superficial burns, wound and trauma surface infestation and festers, and has effects that control bacterium infection, promotes wound repair.
Description
Technical field
The invention belongs to polymeric biomaterial medical dressing technical fields, more particularly to a kind of low molecular weight carboxymethyl
The preparation method of the compound alginic acid dressing of chitosan.
Background technique
Chitin is widely present in marine organisms (such as shrimp, crab) shell and the cell wall of fungi, and chitosan is that its is deacetylated
Change product, as a kind of glycosaminoglycan, biodegradable in vivo has no toxic side effect.The purposes of chitin increasingly causes numerous
The concern and interest of scholar.It due to the water-insoluble of chitin and chitosan, limits its scope of application, therefore, we are to first
Shell element synthesizes carboxylate through certain technique with monoxone, and product carboxymethyl chitosan makes have water solubility.Due to carboxymethyl chitosan
Sugar has the effects that water-soluble well and has film forming, thickening, moisturizing, gelatinization, and these characteristics can be to the healing of wound
Play the role of it is good, it is significantly more efficient to the surface of a wound play hemostasis, antibacterial, promote more, analgesic purpose.Research finds carboxymethyl
Significant positive correlation is had no between the bacteriostasis property and degree of substitution by carboxymethyl of chitosan, but the relationship between molecular weight is in negative
It closes, with the reduction of molecular weight, fungistatic effect is significantly improved, when molecular weight is greater than 1 × 106When, bacteria resistance function is unobvious, when point
Son amount is less than 105When, bacteriostatic activity is remarkably reinforced.Low molecular weight carboxymethyl chitosan be can choose applied to the surface of a wound.
Alginic acid is a kind of natural polysaccharide, is mainly derived from sea-plant Phaeophyceae.The chemical composition of alginic acid is by G unit
With M unit by Isosorbide-5-Nitrae-glucosides key connection, single MMM or GGG or MGGGMM alternate combinations are formd during connection.Perhaps
Mostly the study found that alginate can promote many immunologic functions of macrophage and people's thick liquid cell, having enhances its cell
Dissolution activity and the biology performances such as a large amount of interleukins L of stimulation these cells secretion and interleukin-6.It is defended in medicine
Raw field, for alginate as a kind of functional biomedical material, the Ministry of Public Health, China has promulgated a alginate dressing
Ministry standard (WS1-128-89).As Devoting Major Efforts To Developing utilizes marine resources, alginates are more and more, and to act on the mankind strong
Health field.
The skin of human body is badly damaged by extraneous its defense function of damage, in turn result in body's immunity it is serious under
Drop is easy to cause trauma surface infestation.In the trauma surface infestation of fire victim, staphylococcus aureus, pseudomonas aeruginosa, large intestine angstrom
Uncommon bacterium is the most common pathogen.Research shows that low molecular weight carboxymethyl chitosan all has significant inhibition to above-mentioned pathogen
Effect, and human body is not likely to produce drug resistance.
Therefore, one kind is developed using low molecular weight carboxymethyl chitosan as main functional component, and utilizes alginic acid fibre material
Material itself has effects that the advanced composite material (ACM) of antibacterial heal-promoting function is played in collaboration, is modern medicine function of emergency treatment material neck
The trend of domain development, it is contemplated that such functionality combine dressing has good market prospects.
Summary of the invention
For above-mentioned existing Wound dressing technology, the present invention provides a kind of low molecular weight carboxymethyl chitosan and compounding seas
Alginic acid dressing and preparation method thereof is by carrying out chemistry to low molecular weight medical grade chitosan and repairing using monoxone as modifying agent
Decorations, the low molecular weight carboxymethyl chitosan of preparation by dipping wipe to sop up liquid the techniques such as pressure formed with alginic acid fibre Material cladding it is novel multiple
Close dressing.Dressing of the present invention is suitable for skin superficial burns, wound and trauma surface infestation and festers, and has control bacterium infection, promotees
The effect of into wound repair.
In order to solve the above-mentioned technical problem, a kind of compound alginic acid of low molecular weight carboxymethyl chitosan proposed by the present invention applies
The preparation method of material, comprising the following steps:
Step 1: the preparation sterile low molecular weight carboxymethyl chitosan of medical grade, spare;
Step 2: medical grade alginic acid non-woven fabrics is prepared by needling process by alginate fiber, it is spare;
Step 3: the sterile low molecular weight carboxymethyl chitosan of medical grade that step 1 obtains is fixed on step 2 acquisition
In medical alginic acid non-woven fabrics, to obtain the compound alginic acid dressing of low molecular weight carboxymethyl chitosan, wherein low molecular weight carboxylic
The mass percent of methyl chitosan is 0.1%~8.0%, is preferably 1.2%;Surplus is medical alginic acid non-woven fabrics.
Further, detailed process is as follows for step 1;
Step 1-1, in 105 DEG C of dry low-molecular weight chitoglycan powder 4h, it is according to chitosan and isopropanol quality volume
The ratio of 0.1g/ml is put into flask, and 4h is stirred at room temperature;
Step 1-2, the sodium hydroxide solution of 35wt%, the sodium hydroxide solution and above-mentioned body are added in Xiang Shangshu system
The volume ratio of system is 2:1, is stirred at room temperature uniformly, and alkalization expansion 10h is carried out at -20 DEG C;According to 1ml/3min's in 60 DEG C of water-baths
The pure chloroacetic aqueous isopropanol of analysis that mass-volume concentration is 2g/ml is added dropwise in speed, and it is molten to analyze pure chloroacetic isopropanol
The volume ratio 1:1 of liquid and sodium hydroxide solution reacts 6h in 60 DEG C of water-baths, carries out carboxy methylation, obtains product A;
Step 1-3, it is 100:1 proportion according to the volume ratio of distilled water and product A, product A is sufficiently dissolved, with 50% vinegar
Aqueous acid carries out being neutralized to 3pH=7.0, and Buchner funnel filters separation, and filtrate is used in common after sufficiently being precipitated with dehydrated alcohol
Fast filter paper filtering, is packed into the bag filter for the molecular weight 14000 that shuts off after filtered solid product is washed 5 times with acetone repeatedly
In;
Step 1-4, bag filter is immersed in distilled water and is dialysed for 24 hours, 95% ethanol water is put into after bag filter is taken out
Bag filter is taken out again after middle dialysis for 24 hours;Repeat process 3~4 times of step 1-4;
Step 1-5, the carboxymethyl chitosan sugar aqueous solution in bag filter is precipitated with dehydrated alcohol, solid is taken out after suction filtration and is produced
Object is placed in 60 DEG C of vacuum drying, vacuum degree -0.1MPa, time 5h, after sealed packaging, temperature is 115 DEG C, pressure is
Sterilize 30min under 0.15MPa, can obtain the sterile low molecular weight carboxymethyl chitosan of medical grade.
For the sterile low molecular weight carboxymethyl chitosan molecular weight of the medical grade being prepared between 1W-2W, appearance is in class
White or pale yellow powder, can flow freely, free from extraneous odour, diameter is between 100um-200um, pH=7.5, viscosity 60mpa.s, carboxylic
Methyl substitution 90.2%.
The detailed process of step 3 is: the sterile low molecular weight carboxymethyl chitosan of medical grade for taking step 1 to obtain, configuration
Mass fraction is the low molecular weight carboxymethyl chitosan sugar aqueous solution of 0.32~3.2wt%, at room temperature with the revolving speed magnetic of 120r/min
Power stirs 1h;The medical grade alginic acid non-woven fabrics that step 2 obtains is cut to be impregnated in after the sheet material of required specification above-mentioned
In low molecular weight carboxymethyl chitosan sugar aqueous solution, 60 DEG C of water-bath 40-50r/min shake 1h, are laid on glass after taking-up, with stone roller
After son flattens, 60 DEG C of vacuum drying are placed on, vacuum degree -0.1MPa, time 6h are packaged in medicinal low density polyethylene after taking-up
Alkene bag, sealed after being vacuumized,60Co irradiation dose 25kGy sterilizes for 24 hours, and the compound seaweed of low molecular weight carboxymethyl chitosan is made
Sour dressing.
By the compound alginic acid dressing for the low molecular weight carboxymethyl chitosan that preparation method of the present invention obtains,
With following performance: moisture-vapor transmission is 3027.75g/ (m2·24h)±54.63;Hygroscopicity is 6.33g/g
±0.03;Mechanical stretch performance, in which: ultimate strength is longitudinally 55.17N ± 0.02, is laterally 74.68N ± 0.27;Fracture is stretched
Long rate is longitudinally 81.15% ± 2.66, is laterally 72.61% ± 1.37.
The physical and chemical index having is as follows: ash content is 0.26% ± 0.05;Content of beary metal is 2.23ug/g ± 0.10;Fluorescence
Substance is feminine gender;Infusion pH value is 7.63 ± 0.22;Surface reactive material is feminine gender;In water soluble matter be 5.71% ±
1.24;Soluble matter is 0.23% ± 0.02 in ether;
The anti-microbial property having is as follows: antibacterial bandwidth 2.6mm ± 0.06, remove covering surface after contact zone bacterium without
Breed situation;
The biocompatibility having: sample leaching liquor cell with respect to appreciation rate RGR up to 92.5%, cell-cytotoxic reaction I
Grade;The cellular morphology of 72h leaching liquor is in normal fusiform, and Density Distribution is uniform.
Compared with prior art, the beneficial effects of the present invention are:
Since the alginic acid in composite material has stronger imbibition ability, the low molecular weight carboxylic first of material surface can be made
Base enclosure glycan rapidly releases, so can quickly and effectively inhibit bacterial reproduction.Meanwhile the fully connected topology of alginic acid
Carboxymethyl chitosan is prevented to discharge completely, so that composite material has certain lasting fungistatic effect, effective time be can achieve
48h。
Wherein, the lasting fungistatic effect of composite material the results are shown in Table 1;
1 different multiples minimum bactericidal concentration of table (minimum bactericidal concentration, MBC) compounding sea
The anti-microbial property (n=6) of alginic acid dressing;
Detailed description of the invention
Fig. 1 is the SEM figure of low molecular weight carboxymethyl chitosan contained in dressing of the present invention;
Fig. 2 (a) is the SEM figure of the compound alginic acid dressing surface of low molecular weight carboxymethyl chitosan of the present invention;
Fig. 2 (b) is the SEM figure of the compound alginic acid dressing of low molecular weight carboxymethyl chitosan of the present invention cross section;
Fig. 3 (a) is the compound alginic acid dressing of low molecular weight carboxymethyl chitosan of the present invention antibacterial band biocidal property for 24 hours in vitro
Energy;
Fig. 3 (b) is the bacterial reproduction in the compound alginic acid dressing vitro exposure area of low molecular weight carboxymethyl chitosan of the present invention
Situation;
Fig. 4 is the compound alginic acid dressing vitro cytotoxicity test NCTC of low molecular weight carboxymethyl chitosan of the present invention
Clone929 cell (l cell) × 40 light microscope photo.
Specific embodiment
It is provided in the present invention it is a kind of prepare the sterile low molecular weight carboxymethyl chitosan of medical grade, key step includes: system
The standby sterile low molecular weight carboxymethyl chitosan of medical grade;Medical grade seaweed is prepared by needling process by alginate fiber
Sour non-woven fabrics;By the sterile low molecular weight carboxymethyl chitosan glycopexis of the medical grade of above-mentioned acquisition (as using dipping boulton process)
In above-mentioned medical alginic acid non-woven fabrics (it is unrestricted that the alginic acid diverts from one use to another the preparation process in non-woven fabrics), to obtain low
The compound alginic acid dressing of molecular weight carboxymethyl chitosan, wherein the mass percent of low molecular weight carboxymethyl chitosan is 0.1%
~8.0%, surplus is medical alginic acid non-woven fabrics.
Wherein, the process for preparing the sterile low molecular weight carboxymethyl chitosan of medical grade is as follows;
In 105 DEG C of dry low-molecular weight chitoglycan powder, the ratio for being 0.1g/ml according to chitosan and isopropanol quality volume
Example is put into flask, and 4h is stirred at room temperature, is swollen it sufficiently;The sodium hydroxide of the 35wt% of 2 times of above-mentioned system volumes is added
Solution is stirred at room temperature uniformly, and alkalization expansion 10h is carried out at -20 DEG C;According to the speed of 1ml/3min in 60 DEG C of water-baths, matter is added dropwise
The pure chloroacetic aqueous isopropanol of analysis that volumetric concentration is 2g/ml is measured, pure chloroacetic aqueous isopropanol and hydroxide are analyzed
The volume ratio 1:1 of sodium solution, 6h is reacted in 60 DEG C of water-baths, is carried out carboxymethylation reaction, is obtained product A;After reaction,
The distilled water of 100 times of product A is added, product A is sufficiently dissolved, is carried out being neutralized to pH=7.0, cloth with 50% aqueous acetic acid
Family name's funnel filters separation, and filtrate is sufficiently precipitated with dehydrated alcohol, filtered with ordinary filter paper, by head product low molecular weight carboxymethyl shell
Glycan is fitted into the bag filter for the molecular weight 14000 that shuts off after washing 5 times repeatedly, is immersed in distilled water and is dialysed for 24 hours, taking-up is put into
It dialyses in 95% ethanol water for 24 hours, takes out be put into distilled water again, 7d is purified repeatedly;Finally in bag filter
Carboxymethyl chitosan sugar aqueous solution is precipitated with dehydrated alcohol, and sediment is filtered, and 60 DEG C of vacuum drying, vacuum degree-are put into after taking-up
0.1MPa, time 5h, after sealed packaging, sterilize 30min in the case where temperature is 115 DEG C, pressure is 0.15MPa, can obtain medical grade
Sterile low molecular weight carboxymethyl chitosan.
The concentration of the sterile low molecular weight carboxymethyl chitosan of above-mentioned medical grade of compound alginic acid dressing load is sieved
Choosing, referring to the evaluation third portion of GB/T20944.3-2008 antibacterial textile performance: succusion, 37 DEG C are cultivated for 24 hours and after 48h,
A series of low molecular weight carboxymethyl chitosan of different quality concentration is measured in wavelength 475nm absorbance, it is determined that above-mentioned medical
The sterile low molecular weight carboxymethyl chitosan three kinds of mixing bacterium colony common to wound of grade (including staphylococcus aureus ATCC 6538,
Large intestine Erichsen bacterium 8099 and pseudomonas aeruginosa CMCC (B) 10010, and the concentration of three kinds of mixing bacterium colonies is 1*108) minimum suppression
Bacteria concentration (MIC) and minimum bactericidal concentration (MBC), outcome quality concentration are 0.156% and 0.3125%.
For the sterile low molecular weight carboxymethyl chitosan molecular weight of medical grade of the present invention between 1W-2W, appearance is in off-white color or light
Yellow powder can flow freely, free from extraneous odour, and diameter takes between 100um-200um, Ph value 7.5, viscosity 60mpa.s, carboxymethyl
For degree 90.2%.
In the compound alginic acid dressing of low molecular weight carboxymethyl chitosan of the present invention, low molecular weight carboxymethyl chitosan accounts for compound
Alginic acid dressing mass percent is 0.1%~8.0%.And it is prepared according to the following steps: takes in right amount according to above-mentioned preparation method
The sterile low molecular weight carboxymethyl chitosan of medical grade obtained configures the medical grade low molecular weight carboxymethyl of 0.32~3.2wt%
Chitosan aqueous solution, magnetic agitation 120r/min about 1h is until clear is presented in solution at room temperature;By above-mentioned acquisition
Alginic acid non-woven fabrics is impregnated in above-mentioned low molecular weight carboxymethyl chitosan after cutting out the alginic acid nonwoven fabric sheets of various effective specifications
In sugar aqueous solution, 60 DEG C of water-bath 40-50r/min shake 1h, come into full contact with alginic acid non-woven fabrics with carboxymethyl chitosan solution,
It is laid on glass after taking-up, after being flattened with roller, is placed in 60 DEG C of vacuum oven vacuum drying, vacuum degree -0.1MPa, about
5h;Medicinal low density polyethylene (LDPE) bag is packaged in after taking-up, sealed after being vacuumized uses60The sterilizing of Co- gamma-ray irradiation, dosage
25kGy, sterilization time for 24 hours, finally prepare the compound alginic acid dressing of low molecular weight carboxymethyl chitosan.
The compound alginic acid dressing of low molecular weight carboxymethyl chitosan of the present invention has good moisture-vapor transmission, moisture absorption
Property, mechanical stretch performance, in which:
Moisture-vapor transmission: data measured is 3027.75g/ (m224h) ± 54.63;
Hygroscopicity: data measured is 6.33g/g ± 0.03;
Mechanical stretch performance: data measured is ultimate strength longitudinal direction 55.17N ± 0.02, lateral 74.68N ± 0.27;Fracture
Elongation longitudinal 81.15% ± 2.66, lateral 72.61% ± 1.37;
Every physical and chemical index of the compound Wound dressing of the present invention meets industry internal standard, in which:
Ash content: data measured is 0.26% ± 0.05;
Content of beary metal: data measured is 2.23ug/g ± 0.10;
Fluorescent material: data measured is feminine gender;
Infusion pH value: data measured is 7.63 ± 0.22;
Surface reactive material: data measured is feminine gender;
Soluble matter in water: data measured is 5.71% ± 1.24;
Soluble matter in ether: data measured is 0.23% ± 0.02;
The compound Wound dressing of the present invention has good anti-microbial property and biocompatibility, in which:
Anti-microbial property: antibacterial bandwidth 2.6mm ± 0.06, the bacterium of the contact zone after removing covering surface is without breeding situation
Biocompatibility: sample leaching liquor cell can achieve 92.5% with respect to appreciation rate RGR, cell-cytotoxic reaction I
Grade.The cellular morphology of its 72h leaching liquor is in normal fusiform, and Density Distribution is uniform,
To sum up, low molecular weight carboxymethyl of the present invention is shown by the optimization of technique preparation process and wound dressing analysis detection
The compound alginic acid dressing of chitosan has good absorbent, is capable of the tissue fluid of the efficient absorption surface of a wound, meanwhile, have certain
Moisture-vapor transmission, balance the physiological humidity of the surface of a wound, accelerate to promote wound healing.Natural biologic material therein passes through excellent
Change the techniques such as compound, has effects that significantly to inhibit to surface of a wound common bacteria, while passing through the topological structure of alginic acid non-woven fabrics
It can make combine dressing of the invention that there is the bacteriostasis of 48h.It appropriate can slow down the replacement frequency of dressing, to mitigate
The financial burden of patient.
The compound alginic acid dressing raw material sources of low molecular weight carboxymethyl chitosan of the present invention are extensive, and preparation process is simply easy
It realizes, product resultant effect is significant, and some shortcomings of the dressing of the existing surface of a wound of solution in production application has
Certain economy and society value.The compound alginic acid dressing of low molecular weight carboxymethyl chitosan of the present invention combines two kinds natural high
The biological sexual clorminance of molecular polysaccharide has good gas permeability, mechanical stretch, hygroscopicity, antibiotic property and biocompatibility, energy
The wettability physiological environment of enough feasible simulation surface of a wound, effectively facilitates wound healing.Preparation process is relatively easy, and scale production can
Row is strong.
Technical solution of the present invention is described in further detail in the following with reference to the drawings and specific embodiments, it is described specific
Embodiment is only explained the present invention, is not intended to limit the invention.
Embodiment one: the preparation and particle diameter distribution of low molecular weight carboxymethyl chitosan
The dry medical grade low-molecular weight chitoglycan powder of 1g is taken to be put into flask, 10ml isopropanol, which is added, and is stirred at room temperature makes it
Sufficiently swelling, about 4h;20ml 35wt% sodium hydroxide solution is added to be stirred at room temperature uniformly, -20 DEG C carry out alkalization expansion, about
10h.1h drips off the pure chloroacetic aqueous isopropanol of analysis that 20ml mass-volume concentration is 2g/ml in 60 DEG C of water-baths, at 60 DEG C
6h is reacted in water-bath, carries out carboxy methylation;50mL distilled water is added after reaction, product is sufficiently dissolved, with 50% acetic acid
It being neutralized, pH value is made to reach 7.0, Buchner funnel filters separation, and filtrate is sufficiently precipitated with dehydrated alcohol, ordinary filter paper filtering,
It washs 5 times, is fitted into bag filter (shut off molecular weight 14000) repeatedly, be immersed in distilled water and dialyse for 24 hours, taking-up is put into 95% second
It dialyses in alcohol for 24 hours, takes out be put into distilled water again, 7d is purified repeatedly, finally the carboxymethyl chitosan in bag filter
Aqueous solution is precipitated with dehydrated alcohol, 60 DEG C, vacuum degree -0.1MPa, time 5h of vacuum drying after taking out after pumping rate, after sealed packaging
115 DEG C of high temperature and pressure, 30min sterilizing can obtain the sterile low molecular weight carboxymethyl chitosan of medical grade.
Above-mentioned carboxymethyl chitosan is ground in powdered with ball mill or mortar, takes to be evenly distributed in right amount and is stained with conduction
It on the silicon wafer of glue, is fixed on sample copper platform, vacuum metal spraying 10min, the form of scanning electron microscopic observation sample, size and table
Face, the result is shown in Figure 1 show sample in the form of sheets, and diameter is between 100um-200um, and surface is with the presence of certain concave-convex fold.
Embodiment two: the preparation of the compound alginic acid dressing of low molecular weight carboxymethyl chitosan
The sterile low molecular weight carboxymethyl chitosan configuration quality concentration of the medical grade being prepared using embodiment 1 is
3.0% low molecular weight carboxymethyl chitosan sugar aqueous solution, 25 DEG C of room temperature magnetic agitation 120r/min about 1h are clear until solution presentation
It is clear it is bright until;The alginic acid non-woven fabrics for cutting out 2.5cm*2.5cm is impregnated in above-mentioned solution, 60 DEG C of water-bath 40-50r/min shakes
1h is swung, alginic acid non-woven fabrics is come into full contact with carboxymethyl chitosan, is laid on glass after taking-up, after being flattened with roller, is put
60 DEG C of vacuum oven are placed in, vacuum degree -0.1MPa, about 5h;It takes out afterwards and is packaged in medicinal low density polyethylene (LDPE) bag, after vacuumizing
Sealing uses60The sterilizing of Co- gamma-ray irradiation, dosage 25kGy, time for 24 hours, finally prepare low molecular weight carboxymethyl chitosan
Compound alginic acid dressing.
The compound alginic acid dressing for the low molecular weight carboxymethyl chitosan that the present invention prepares must be kept in dark place.
The SEM stereoscan photograph surface of the compound alginic acid dressing of low molecular weight carboxymethyl chitosan made from embodiment two
It is shown with cross section such as Fig. 2 (a) and Fig. 2 (b).
The physicochemical property for the compound alginic acid dressing that embodiment two obtains is examined referring to national standard and professional standard
It surveys, specific as follows:
Moisture-vapor transmission is referring to " YY/T0471.2-2004 contact Wound dressing test method part 2: ventilative to apply
Expect moisture-vapor transmission ", data measured 3027.75g/m2·24h±54.63。
Hygroscopicity reference " YY/T0471.2-2004 contact Wound dressing test method part 1: liquid-absorbent ",
Data measured is 6.33g/g ± 0.03.
Mechanical stretch performance is surveyed referring to " measurement of FZ/T 60005-90 non-woven cloth ultimate strength and elongation at break "
Obtaining data is ultimate strength longitudinal direction 55.17N ± 0.02, lateral 74.68N ± 0.27;Elongation at break longitudinal 81.15% ±
2.66, lateral 72.61% ± 1.37.
For ash content referring to " 05 edition CP, mono- Ⅸ K of annex ", data measured is 0.26% ± 0.05.
Referring to " GB/T11593-1998 textile detection of heavy metal ion method ", data measured is content of beary metal
2.23ug/g±0.10。
For fluorescent material referring to " YY/T0471.2-2004 contact Wound dressing test method ", data measured is feminine gender.
Referring to " YY/T0471.2-2004 contact Wound dressing test method ", data measured is infusion pH value
7.63±0.22。
For surface reactive material referring to " YY/T0471.2-2004 contact Wound dressing test method ", data measured is yin
Property.
Referring to " YY/T0471.2-2004 contact Wound dressing test method ", data measured is soluble matter in water
5.71% ± 1.24.
Referring to " YY/T0471.2-2004 contact Wound dressing test method ", data measured is soluble matter in ether
0.23% ± 0.02.
Reference standard " the evaluation part 1 of GB/T20944.1-2007 antibacterial textile performance: agar plate diffusion method "
Operate the auxiliary material progress in-vitro antibacterial performance evaluation obtained to embodiment two, as the result is shown dressing of the present invention it is common for the surface of a wound by
Try the year-on-year of strain staphylococcus aureus ATCC 6538, large intestine Erichsen bacterium 8099 and pseudomonas aeruginosa CMCC (B) 10010
The antibacterial bandwidth for 24 hours of example mixing can achieve 2.6mm ± 0.06, and remove the bacterium of the contact zone after covering surface without numerous
Situation is grown, effect is good, referring to Fig. 3 (a) and Fig. 3 (b).
Biocompatibility analysis: reference standard " GB/T16886.5-2003 medical treatment is carried out to the auxiliary material that embodiment two obtains
The 5th part of instrument biological assessment: vitro cytotoxicity test " uses mtt assay therein, and sample leaching liquor cell is opposite to rise in value
Rate RGR can achieve 92.5%, and cell-cytotoxic reaction is I grade.The cellular morphology of its 72h leaching liquor is in normal fusiform, and density
It is evenly distributed, referring to fig. 4.
Although above in conjunction with figure, invention has been described, and the invention is not limited to above-mentioned specific embodiment parties
Formula, the above mentioned embodiment is only schematical, rather than restrictive, and those skilled in the art are in this hair
Under bright enlightenment, without deviating from the spirit of the invention, many variations can also be made, these belong to guarantor of the invention
Within shield.
Claims (3)
1. a kind of preparation method of the compound alginic acid dressing of low molecular weight carboxymethyl chitosan, which is characterized in that by following steps
Composition:
Step 1: the preparation sterile low molecular weight carboxymethyl chitosan of medical grade, spare;
Step 1 the following steps are included:
It step 1-1, is 0.1g/ according to chitosan and isopropanol quality volume in 105 DEG C of dry low-molecular weight chitoglycan powder 4h
The ratio of ml is put into flask, and 4h is stirred at room temperature;
Step 1-2, the sodium hydroxide solution of 35wt%, the sodium hydroxide solution and above-mentioned system are added in Xiang Shangshu system
Volume ratio is 2:1, is stirred at room temperature uniformly, and alkalization expansion 10h is carried out at -20 DEG C;According to the speed of 1ml/3min in 60 DEG C of water-baths
The pure chloroacetic aqueous isopropanol of analysis that mass-volume concentration is 2g/ml is added dropwise, analyze pure chloroacetic aqueous isopropanol with
The volume ratio 1:1 of sodium hydroxide solution reacts 6h in 60 DEG C of water-baths, carries out carboxy methylation, obtains product A;
Step 1-3, it is 100:1 proportion according to the volume ratio of distilled water and product A, product A is sufficiently dissolved, with 50% acetic acid water
Solution be neutralized to pH=7.0, and Buchner funnel filters separation, filtrate sufficiently precipitated with dehydrated alcohol after with common Medium speed filter paper
Filtering, is fitted into the bag filter for the molecular weight 14000 that shuts off after filtered solid product is washed 5 times with acetone repeatedly;
Step 1-4, bag filter is immersed in distilled water and is dialysed for 24 hours, is put into after bag filter is taken out in 95% ethanol water thoroughly
Bag filter is taken out again after analysis for 24 hours;Repeat process 3~4 times of step 1-4;
Step 1-5, the carboxymethyl chitosan sugar aqueous solution in bag filter is precipitated with dehydrated alcohol, solid product is taken out after suction filtration and is set
It is dried in vacuo in 60 DEG C, vacuum degree -0.1MPa, time 5h, after sealed packaging, in the case where temperature is 115 DEG C, pressure is 0.15MPa
Sterilize 30min, can obtain the sterile low molecular weight carboxymethyl chitosan of medical grade;
Step 2: medical grade alginic acid non-woven fabrics is prepared by needling process by alginate fiber, it is spare;
Step 3: the sterile low molecular weight carboxymethyl chitosan of medical grade that step 1 obtains is fixed on the medical of step 2 acquisition
In alginic acid non-woven fabrics, to obtain the compound alginic acid dressing of low molecular weight carboxymethyl chitosan, wherein low molecular weight carboxymethyl
The mass percent of chitosan is 0.1%~8.0%, and surplus is medical alginic acid non-woven fabrics;
Step 3 the following steps are included:
The sterile low molecular weight carboxymethyl chitosan of medical grade for taking step 1 to obtain, configuration quality score are 0.32~3.2wt%
Low molecular weight carboxymethyl chitosan sugar aqueous solution, at room temperature with the revolving speed magnetic agitation 1h of 120r/min;
It is cut to the medical grade alginic acid non-woven fabrics that step 2 obtains to be impregnated in above-mentioned low point after the sheet material of required specification
In son amount carboxymethyl chitosan sugar aqueous solution, 60 DEG C of water-bath 40-50r/min shake 1h, are laid on glass after taking-up, with roller pressure
After smooth, 60 DEG C of vacuum drying are placed on, vacuum degree -0.1MPa, time 6h are packaged in medicinal low density polyethylene (LDPE) after taking-up
Bag, sealed after being vacuumized,60Co irradiation dose 25kGy sterilizes for 24 hours, and the compound alginic acid of low molecular weight carboxymethyl chitosan is made
Dressing;
For the sterile low molecular weight carboxymethyl chitosan molecular weight of medical grade between 1W-2W, appearance is in off-white color or yellowish toner
End can flow freely, free from extraneous odour, and diameter is between 100um-200um, pH=7.5, viscosity 60mpa.s, degree of substitution by carboxymethyl
90.2%.
Low point that 2. the preparation method of the compound alginic acid dressing of low molecular weight carboxymethyl chitosan according to claim 1 obtains
The compound alginic acid dressing of son amount carboxymethyl chitosan, has following performance:
Moisture-vapor transmission is 3027.75g/ (m2·24h)±54.63;
Hygroscopicity is 6.33g/g ± 0.03;
Mechanical stretch performance, in which: ultimate strength is longitudinally 55.17N ± 0.02, is laterally 74.68N ± 0.27;Extension at break
Rate is longitudinally 81.15% ± 2.66, is laterally 72.61% ± 1.37.
3. the compound alginic acid dressing of low molecular weight carboxymethyl chitosan according to claim 2, which is characterized in that
The physical and chemical index having is as follows: ash content is 0.26% ± 0.05;Content of beary metal is 2.23ug/g ± 0.10;Fluorescent material
For feminine gender;Infusion pH value is 7.63 ± 0.22;Surface reactive material is feminine gender;Soluble matter is 5.71% ± 1.24 in water;
Soluble matter is 0.23% ± 0.02 in ether;
The anti-microbial property having is as follows: antibacterial bandwidth 2.6mm ± 0.06, and the bacterium of the contact zone after removing covering surface is without breeding
Situation;
The biocompatibility having: for sample leaching liquor cell with respect to appreciation rate RGR up to 92.5%, cell-cytotoxic reaction is 1 grade;
The cellular morphology of 72h leaching liquor is in normal fusiform, and Density Distribution is uniform.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610103647.6A CN105664224B (en) | 2016-02-25 | 2016-02-25 | A kind of compound alginic acid dressing of low molecular weight carboxymethyl chitosan and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610103647.6A CN105664224B (en) | 2016-02-25 | 2016-02-25 | A kind of compound alginic acid dressing of low molecular weight carboxymethyl chitosan and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105664224A CN105664224A (en) | 2016-06-15 |
CN105664224B true CN105664224B (en) | 2019-05-28 |
Family
ID=56305032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610103647.6A Active CN105664224B (en) | 2016-02-25 | 2016-02-25 | A kind of compound alginic acid dressing of low molecular weight carboxymethyl chitosan and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105664224B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107237005B (en) * | 2017-06-19 | 2020-06-09 | 山东大学 | Alginic acid and chitosan double-component fiber and preparation method thereof |
CN109362952A (en) * | 2018-10-19 | 2019-02-22 | 吉林省惠森食品有限公司 | A kind of selenium-rich high-efficiency livestock and poultry enteron aisle ecological regulator and preparation method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040101547A1 (en) * | 2002-11-26 | 2004-05-27 | Pendharkar Sanyog Manohar | Wound dressing containing aldehyde-modified regenerated polysaccharide |
EP1481694A1 (en) * | 2003-05-30 | 2004-12-01 | Ethicon, Inc. | Biodegradable hemostatic wound dressings |
CN1686572A (en) * | 2005-05-13 | 2005-10-26 | 褚省吾 | Ultra strong absorption calcium alginate henatischesis dressing and its preparation method |
CN101569761A (en) * | 2008-12-31 | 2009-11-04 | 褚加冕 | Preparation method for medical honey dressing |
CN102526795A (en) * | 2012-02-15 | 2012-07-04 | 中国人民解放军广州军区武汉总医院 | Chitosan-based styptic sponge and preparation method thereof |
CN102579194A (en) * | 2012-03-07 | 2012-07-18 | 苏州美迪斯医疗运动用品有限公司 | Composite self-adhering elastic bandage for functional biological dressing |
-
2016
- 2016-02-25 CN CN201610103647.6A patent/CN105664224B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040101547A1 (en) * | 2002-11-26 | 2004-05-27 | Pendharkar Sanyog Manohar | Wound dressing containing aldehyde-modified regenerated polysaccharide |
EP1481694A1 (en) * | 2003-05-30 | 2004-12-01 | Ethicon, Inc. | Biodegradable hemostatic wound dressings |
CN1686572A (en) * | 2005-05-13 | 2005-10-26 | 褚省吾 | Ultra strong absorption calcium alginate henatischesis dressing and its preparation method |
CN101569761A (en) * | 2008-12-31 | 2009-11-04 | 褚加冕 | Preparation method for medical honey dressing |
CN102526795A (en) * | 2012-02-15 | 2012-07-04 | 中国人民解放军广州军区武汉总医院 | Chitosan-based styptic sponge and preparation method thereof |
CN102579194A (en) * | 2012-03-07 | 2012-07-18 | 苏州美迪斯医疗运动用品有限公司 | Composite self-adhering elastic bandage for functional biological dressing |
Also Published As
Publication number | Publication date |
---|---|
CN105664224A (en) | 2016-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rafique et al. | Chitosan functionalized poly (vinyl alcohol) for prospects biomedical and industrial applications: A review | |
CN105107008B (en) | A kind of hydroxyl butyl chitosan/oxidized sodium alginate/nano silver composite hydrogel dressing patch | |
CN104257639B (en) | A kind of liniment for Wound treating and preparation method thereof | |
CN105435300B (en) | A kind of antibacterial medical dressing containing nano wire fibroin | |
CN107029272A (en) | A kind of alginate medical dressing and preparation method thereof | |
CN107456321B (en) | A kind of nanometer silver antimicrobial sanitary napkin and its production method | |
CN110448722A (en) | A kind of injectable is containing the temperature sensitive composite antibacterial hydrogel material of tannic acid and its preparation and application | |
Wang et al. | Facile fabrication of self-healing, injectable and antimicrobial cationic guar gum hydrogel dressings driven by hydrogen bonds | |
EP3632477B1 (en) | Antibacterial wound dressing and preparation method and application thereof | |
CN103263434B (en) | Anti-adhesion liquor for wound washing and surgery and preparation method and application of anti-adhesion liquor | |
MX2008000969A (en) | Biomaterials based on carboxymethylcellulose salified with zinc associated with hyaluronic acid derivatives. | |
Singh et al. | Application of tragacanth gum and alginate in hydrogel wound dressing's formation using gamma radiation | |
Lim et al. | Biomedical-grade chitosan in wound management and its biocompatibility in vitro | |
CN103159972A (en) | Preparation method for chitosan and cellulose antibiosis application film of biotin coupling nano silver | |
CN110003359A (en) | A kind of hydrophily high substituted degree modification of chitosan preparation method and applications | |
CN110507842A (en) | A kind of bacteria cellulose/hyaluronic acid/epsilon-polylysine functional form dressing and preparation method thereof | |
CN106692997A (en) | Sterilizing and disinfecting solid-state medical ultrasonic coupling patch and preparation method thereof | |
CN105664224B (en) | A kind of compound alginic acid dressing of low molecular weight carboxymethyl chitosan and preparation method thereof | |
Zhou et al. | A cross-linked hydrogel of bismuth sulfide nanoparticles with excellent photothermal antibacterial and mechanical properties to combat bacterial infection and prompt wound healing | |
CN110124082A (en) | Swelling type medical bio gel filler based on Polysaccharide from Portulaca oleracea and chromocor extract | |
CN103407205B (en) | Konjac glucomannan fiber wet tissue and method for preparing same | |
Han et al. | Multifunctional hemostatic polysaccharide-based sponge enhanced by tunicate cellulose: A promising approach for photothermal antibacterial activity and accelerated wound healing | |
CN100540066C (en) | Medical chitosan dressing and production method thereof | |
CN104666317B (en) | A kind of neonatal umbilical cord antibacterial anti-inflammatory liquid and its preparation method and application | |
CN105126158B (en) | Polysaccharide fiber element hemostasis isolation antibacterial repairs glue and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |